Diphtheria tetanus hepatitis B vaccine - Aventis Pasteur MSDAlternative Names: Diphtheria, Tetanus and Hepatitis B vaccine
Latest Information Update: 13 Aug 2015
At a glance
- Originator Aventis Pasteur (now called sanofi pasteur)
- Class Bacterial vaccines; Hepatitis B vaccines; Peptide vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Diphtheria; Hepatitis B; Tetanus